Synflorix™ (10-valent pneumococcal conjugate vaccine; GlaxoSmithKline Biologicals, Belgium) has been investigated globally to evaluate immunogenicity, safety and reactogenicity with different ...

Amezosvatein has shown excellent immunogenicity and improved tolerability in Phase 2 study -- Medicxi leads round, joined by new investors ...

This application is seeking the use of Synflorix as a paediatric pneumococcal vaccine, for the active immunisation against pneumonia caused by Streptoccuss pneumoniae in infants and children aged ...

As Chairman of Global Vaccines, Dr. Slaoui was directly involved ... Rotarix®, to prevent rotavirus gastroenteritis; and Synflorix, to prevent pneumococcal disease. In 2016, Dr. Slaoui was ...

Former Chair of GSK’s vaccine business and Chief Scientific Advisor to Operation Warp Speed, Moncef Slaoui, to join Curevo as Board Chair SEATTLE, March 17, 2025 (GLOBE NEWSWIRE) -- Curevo ...